ArticleThe journal of prevention of Alzheimer's disease2022

Public Policy Should Foster Alzheimer's Treatment Availability: Comment on the Draft US Medicare Decision to Limit Payment for Aducanumab (AduhelmTM) to Patients Participating in Clinical Trials.

J CummingsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.